A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery
CD45, the leukocyte common antigen, is expressed on almost all cells of the immunological and hematological systems. CD45 expression is related to a variety of diseases, including leukemia and lymphoma. In this study, we analyzed the expression level of CD45 across cancers and evaluated the relation...
Main Authors: | Ni Ye, Jie Cai, Yulong Dong, Huiyao Chen, Zhiyuan Bo, Xiaogang Zhao, Mingyang Xia, Mei Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.928328/full |
Similar Items
-
Identification of SETD4 as an Onco‐Immunological Biomarker Encompassing the Tumor Microenvironment, Prognoses, and Therapeutic Responses in Various Human Cancers
by: Yuyun Zhong, et al.
Published: (2025-01-01) -
CD45RA and CD45RO Are Regulated in a Cell-Type Specific Manner in Inflammation and Sepsis
by: Muhammad G. T. Ahmed, et al.
Published: (2023-07-01) -
DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis
by: Mi Zou, et al.
Published: (2024-12-01) -
Bioinformatics analysis of differential expression of CD44 in glioblastomas and cell experimental validation
by: SUN Xu, LI Shunshun, WANG Dianheng, WANG Zhenfeng
Published: (2024-06-01) -
Are CD45RO+ and CD45RA- genuine markers for bovine memory T cells?
by: Kandel Anmol, et al.
Published: (2022-10-01)